Epigral

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE071N01016
  • NSEID: EPIGRAL
  • BSEID: 543332
INR
866.00
9.15 (1.07%)
BSENSE

Mar 06

BSE+NSE Vol: 65.98 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003523,
    "name": "Epigral",
    "stock_name": "Epigral",
    "full_name": "Epigral Ltd",
    "name_url": "stocks-analysis/epigral",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "866.00",
    "chg": 9.15,
    "chgp": "1.07%",
    "dir": 1,
    "prev_price": "856.85",
    "mcapval": "3,781.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543332,
    "symbol": "EPIGRAL",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE071N01016",
    "curr_date": "Mar 06",
    "curr_time": "",
    "bse_nse_vol": "65.98 k",
    "exc_status": "Active",
    "traded_date": "Mar 06, 2026",
    "traded_date_str": "2026 03 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/epigral-1003523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Epigral Ltd Falls 3.01% Amid 52-Week Low and Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-falls-301-amid-52-week-low-and-market-pressure-3878119",
        "imagepath": "",
        "date": "2026-03-07 12:02:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Mar:</strong> New 52-week low at Rs.822.05 amid sustained downtrend</p>\n                    <p><strong>2 Mar:</strong> Significant gap down opening of 7.93%</p>\n                    <p><strong>4 Mar:</strong> Continued decline with Rs.857.00 close (-1.58%)</p>\n                    <p><strong>6 Mar:</strong> Week closes at Rs.865.95 with a modest 1.06% gain</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.870.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.865.95</div><div class=\"..."
      },
      {
        "title": "Epigral Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-3877773",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EpigralLtd_mojoScore_3877773.png",
        "date": "2026-03-07 10:10:38",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Epigral Ltd Opens with Significant Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-opens-with-significant-gap-down-amid-market-concerns-3865256",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EpigralLtd_gapdown_3865256.png",
        "date": "2026-03-02 13:34:28",
        "description": "Epigral Ltd, a specialty chemicals company, opened the trading session with a pronounced gap down, reflecting heightened market concerns following a series of negative performance indicators and a downgrade in its mojo grade. The stock’s opening price plunged by 7.93%, marking a fresh 52-week low and continuing a downward trend that has persisted over the past week."
      },
      {
        "title": "Epigral Ltd Stock Falls to 52-Week Low of Rs 822.05 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-stock-falls-to-52-week-low-of-rs-82205-amid-continued-downtrend-3864979",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EpigralLtd_priceRelatedfactors_3864979.png",
        "date": "2026-03-02 13:05:06",
        "description": "Epigral Ltd, a key player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.822.05 today, marking a significant decline amid a sustained downward trend. The stock’s performance continues to lag behind its sector and broader market indices, reflecting ongoing pressures on its financial metrics and market valuation."
      },
      {
        "title": "Epigral Ltd Stock Falls to 52-Week Low of Rs 901.6 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-stock-falls-to-52-week-low-of-rs-9016-amid-continued-downtrend-3860452",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/EpigralLtd_priceRelatedfactors_3860452.png",
        "date": "2026-02-27 14:36:20",
        "description": "Epigral Ltd, a player in the Specialty Chemicals sector, recorded a fresh 52-week low of Rs.901.6 today, marking a significant milestone in its ongoing price decline. The stock has underperformed its sector and broader market indices, reflecting a challenging period for the company’s equity performance."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-3852494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/EpigralLtd_mojoScore_3852494.png",
        "date": "2026-02-24 10:11:08",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-3834691",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/EpigralLtd_mojoScore_3834691.png",
        "date": "2026-02-12 10:11:11",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Epigral Ltd Falls 4.65% Amid Volatility: 2 Key Trading Days Define Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-falls-465-amid-volatility-2-key-trading-days-define-week-3825927",
        "imagepath": "",
        "date": "2026-02-07 11:02:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock hits 52-week low at Rs.933.45 amid ongoing downtrend</p>\n                    <p><strong>3 Feb:</strong> Strong intraday rally with 7.8% surge to Rs.1,001.65</p>\n                    <p><strong>4 Feb:</strong> Minor correction with a 0.71% decline</p>\n                    <p><strong>5 Feb:</strong> Continued downward pressure, closing at Rs.1,003.85</p>\n                    <p><strong>6 Feb:</strong> Week ends with a 1.34% drop to Rs.990.40</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs..."
      },
      {
        "title": "Epigral Ltd Hits Intraday High with Strong 7.8% Surge on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-hits-intraday-high-with-strong-78-surge-on-3-feb-2026-3818542",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/EpigralLtd_priceRelatedfactors_3818542.png",
        "date": "2026-02-03 12:01:26",
        "description": "Epigral Ltd recorded a robust intraday performance on 3 Feb 2026, surging to a day’s high of Rs 1001.65, marking a 7.98% increase from the previous close. The stock outperformed its sector and the broader market, reflecting notable trading momentum within the Specialty Chemicals industry."
      }
    ],
    "total": 594,
    "sid": "1003523",
    "stock_news_url": "https://www.marketsmojo.com/news/epigral-1003523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "27-Feb-2026",
      "details": "Epigral Limited has informed that the Company is having One-on-One V.C. with Investor / Analyst on 2nd March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-Feb-2026",
      "details": "Epigral Limited has informed the Exchange about Participation in Conference and One-on-One Meeting with Analyst / Investor on 10.02.2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "03-Feb-2026",
      "details": "Epigral Limited submits Transcript of Conference Call held on Friday 30th January 2026 for Q3 FY26 - Results.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Epigral Ltd has declared <strong>25%</strong> dividend, ex-date: 07 Feb 25",
          "dt": "2025-02-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Epigral Ltd Falls 3.01% Amid 52-Week Low and Market Pressure

2026-03-07 12:02:08

Key Events This Week

2 Mar: New 52-week low at Rs.822.05 amid sustained downtrend

2 Mar: Significant gap down opening of 7.93%

4 Mar: Continued decline with Rs.857.00 close (-1.58%)

6 Mar: Week closes at Rs.865.95 with a modest 1.06% gain

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

27-Feb-2026 | Source : BSE

Epigral Limited has informed that the Company is having One-on-One V.C. with Investor / Analyst on 2nd March 2026.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

06-Feb-2026 | Source : BSE

Epigral Limited has informed the Exchange about Participation in Conference and One-on-One Meeting with Analyst / Investor on 10.02.2026.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

03-Feb-2026 | Source : BSE

Epigral Limited submits Transcript of Conference Call held on Friday 30th January 2026 for Q3 FY26 - Results.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Epigral Ltd has declared 25% dividend, ex-date: 07 Feb 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available